Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
521 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
 		Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2019
522 Matrix Metalloproteinase-2 Single Nucleotide Polymorphism in Egyptian Non-Hodgkin Lymphoma Patients: Correlation with Clinicopathological Characteristics and Outcome Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2019
523 Effect of preperitoneal versus epidural analgesia on postoperative inflammatory response and pain following radical cystectomy: A prospective, randomized trial Department of Anesthesia, Intensive care and Pain management Dr. Fatma Adel Abd Diab. 2019
524 Prognostic Significance of Absolute
Lymphocytic Count Recovery in Pediatric
Patients with Acute Lymphoblastic Leukemia at
South Egypt Cancer Institute 		Department of Pediatric Oncology Dr. Azaa Shibl Sayed Mahmoud 2019
525 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
 		Department of Medical Oncology Nehal Adel Rayan Mohammed 2019
526 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
 		Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2019
527 Complication versus Radicality in Papillary Thyroid Cancer Surgery: How to Keep the Balance? Department of Surgical Oncology Mohamed Ismail Omar Ali 2019
528 Complication versus Radicality in Papillary Thyroid Cancer Surgery: How to Keep the Balance? Department of Surgical Oncology Dr. Badawy, Mohammed Ahmed Mohammed 2019
529 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
 		Department of Clinical Pathology Asmaa Ahmed Mohamed ahmed 2019
530 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
 		Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2019